Process Stability Evaluation Strategy and Analysis of Pharmaceutical Excipients Silicon Dioxide
Wang Xiaofeng1, Zhang Jing1, Wang Huijuan1, Wang Lulu1, Yang Rui1, Yang Huiying1, Zhang Yuanyuan2
Author information+
(1)National Institutes for Food and Drug Control, Beijing 100050 , China ;NMPA Key Laboratory for QualityResearch and Evaluation of Pharmaceutical Excipients, Beijing 100050 , China; (2)Proumid GmbH &Co.KG,Beijing 100027 , China
Objective: Based on the equally important quality standard itemsand functionality-related characteristics, to put forward a process stability evaluation strategy as a new method for the process stability control of pharmaceutical excipients. Methods: Firstly, the quality standard items (loss on drying, ignition loss, pH and content) and functionality-related items (moisture absorption, specific surface area, particle size, and particle size distribution) of a total of 14 batches of silica from manufacturers A and B were determined. Subsequently, the quality standard items stability difference (PQ) and functionality-related characteristics stability difference (PF) were obtained by the process stability evaluation strategy. Results: The PQ values of silica of manufacturers A and B were 31.1% and 58.1%, and the PF values were 15.6% and 50.0%, respectively. Conclusion: By comparing PQ values and PF values of two manufacturers, it could refl ect the quality of product impurity control effect of specific manufacturers, the control of functionality-relatedcharacteristics and the difference in control requirements, so as to fully reflect the process stability control of specific manufacturers on their products. The PQ value and PF value provide a comprehensive and eff ective method for monitoring the process stability evaluation of silica, which can provide a reference for the process stability evaluation monitoring of other pharmaceutical excipients.
Wang Xiaofeng, Zhang Jing, Wang Huijuan, Wang Lulu, Zhang Yuanyuan, Yang Rui, Yang Huiying.
Process Stability Evaluation Strategy and Analysis of Pharmaceutical Excipients Silicon Dioxide[J]. Chinese Pharmaceutical Affairs, 2023, 37(9): 1001-1006 https://doi.org/10.16153/j.1002-7777.2023.09.003
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
参考文献
[1] 何仲贵.药用辅料在仿制药质量和疗效一致性评价中的作用[J].中国食品药品监管,2018,176(9):44-46. [2] Dave VS,SD Saoji,NA Raut,et al.Excipient Variability and Its Impact on Dosage Form Functionality[J].Journal of Pharmaceutical Sciences,2015,104(3):906-915. [3] Gao Y,Y Zhang,Y Hong,et al.Multifunctional Role of Silica in Pharmaceutical Formulations[J].AAPS Pharm SciTech,2022,23(4):1-10. [4] MüllerA-K,J Ruppel,C-P Drexel,et al.Precipitated silica as Flow Regulator[J].European Journal of Pharmaceutical Sciences,2008,34(4-5):303-308. [5] Min J,S Baek,P Somasundaran,et al.Anti-Adhesive Behaviors between Solid Hydrate and Liquid Aqueous Phase Induced by Hydrophobic Silica Nanoparticles[J].Langmuir,2016,32(37):9513-9522. [6] Chirsty AA,P Sivarukshy.Comparison of Adsorption Properties of Commercial Silica and Rice Husk Ash(RHA)Silica:A Study by NIR Spectroscopy[J].Open Chemistry,2021,19(1):426-431. [7] 门靖,贾玮,王伟,等.药用辅料二氧化硅在医药制剂中的应用研究进展[J].有机硅材料,2018,32(5):416-420. [8] Sun WJ,A Aburub,CC Sun.A Mesoporous Silica Based Platform to Enable Tablet Formulations of Low Dose Drugs by Direct Compression[J].Int J Pharm,2018,539(1-2):184-189. [9] 国家药典委员会.中华人民共和国药典[M].北京:中国医药科技出版社,2020:580. [10] 张孝娜,孙会敏,王珏,等.羧甲基纤维素钠质量一致性评价及性能参数智能可视化研究[J].药学学报,2020,55(8):1923-1931. [11] 刘威,李三鸣,杨白雪,等.国产羟丙基纤维素L-11批间重现性及其在一致性评价中的意义[J].沈阳药科大学学报,2020,37(9):778-788. [12] Wang H,M Chen,J Li,et al.Quality Consistency Evaluation of Kudiezi Injection Based on Multivariate S t a t i s t i c a l A n a l y s i s o f t h e M u l t i d i m e n s i o n a l Chromatographic Fingerprint[J].Journal of Pharmaceutical a n d B i o m e d i c a l A n a l y s i s,2 0 2 0,1 7 7(1):112868. [13] Zhao A,L Xiao,S Chen,et al.Comprehensive Quality Consistency Evaluation Strategy and Analysis of Compound Danshen Tablet[J].J Pharm Biomed Anal,2022,219(13):114951. [14] Ono T,E Yonemochi.Evaluation of the Physical Properties of Dry Surface-modified Ibuprofen Using a Powder Rheometer(FT4)and Analysis of the Influence of Pharmaceutical Additives on Improvement of the Powder Flowability[J].Int J Pharm,2020,579(7):1-10. [15] Sharma R,G Setia.Enhancing Flowability of Fine Cohesive Active Pharmaceutical Ingredients[J].Drug Dev Ind Pharm,2021,47(7):1140-1152.